Caspofungin enhances the potency of rifampin against Gram-negative bacteria
Our results illustrate the feasibility of CAS as an antibiotic adjuvant against GNB, which is an alternative strategy of anti-infection.
Authors
- Changjiang Dong
- Haotian Li (ORCID: https://orcid.org/0000-0002-0720-0262)
- Xiaojing Zhu (ORCID: https://orcid.org/0000-0002-2818-517X)
- Xing Zhang (ORCID: https://orcid.org/0000-0002-8532-6928)
Institutions
- Wuhan University (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2024-08-15
- DOI
- https://doi.org/10.3389/fmicb.2024.1447485
- Citations
- 2
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.69
Funders
- National Natural Science Foundation of China